Russell Investments Group’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $572 | Buy |
+481
| New | +$572 | ﹤0.01% | 3733 |
|
|
2025
Q1 | – | Sell |
-223
| Closed | -$1.34K | – | 3791 |
|
|
2024
Q4 | $1.34K | Sell |
223
-35
| -14% | -$211 | ﹤0.01% | 3499 |
|
|
2024
Q3 | $1.81K | Sell |
258
-911
| -78% | -$6.38K | ﹤0.01% | 3393 |
|
|
2024
Q2 | $6.78K | Buy |
1,169
+946
| +424% | +$5.49K | ﹤0.01% | 3156 |
|
|
2024
Q1 | $1.59K | Buy |
+223
| New | +$1.59K | ﹤0.01% | 3096 |
|